{"schema_version":"secwatch.filing_event.v1","accession":"0001411690-22-000028","form_type":"8-K","ticker":"BNGO","cik":"0001411690","company_name":"Bionano Genomics, Inc.","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.519615+00:00","generated_at":"2026-06-22T08:37:38.447637+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bionano Genomics reports Q3 2022 revenue of $7.2M, up 55% YoY; guides Q4 $7.5-8M","bullets":["Revenue $7.2M, up 55% YoY and 8% sequentially; gross margin 25%, up 3% sequentially.","Installed base of Saphyr systems increased to 217, up 11% sequentially and 54% YoY; record flowcell sales of 3,975.","GAAP operating expense $34.0M; non-GAAP $26.4M; cash $180.2M.","Q4 2022 revenue guidance $7.5M to $8M.","Bionano Laboratories received CLIA certification; launched first OGM-based LDT."],"urls":{"canonical":"https://secwatch.observer/filing/0001411690-22-000028","json":"https://secwatch.observer/filing/0001411690-22-000028.json","markdown":"https://secwatch.observer/filing/0001411690-22-000028.md","text":"https://secwatch.observer/filing/0001411690-22-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411690/000141169022000028/0001411690-22-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411690/000141169022000028/bngo-20221103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T08:37:38.447637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5dd60765822b235d95cde82fe007cbaf6b5daaf8","claim":"Bionano Genomics, Inc. reported financial results for third quarter ended September 30, 2022.","evidence_excerpt":"On November 3, 2022 , Bionano Genomics, Inc. (the “Company”) issued a press release reporting its financial results for the third quarter ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169022000028/0001411690-22-000028-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}